These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

900 related items for PubMed ID: 11228049

  • 21. Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells.
    Morrione A, Romano G, Navarro M, Reiss K, Valentinis B, Dews M, Eves E, Rosner MR, Baserga R.
    Cancer Res; 2000 Apr 15; 60(8):2263-72. PubMed ID: 10786694
    [Abstract] [Full Text] [Related]

  • 22. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I.
    Imai Y, Clemmons DR.
    Endocrinology; 1999 Sep 15; 140(9):4228-35. PubMed ID: 10465296
    [Abstract] [Full Text] [Related]

  • 23. Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells.
    Kim B, van Golen CM, Feldman EL.
    Endocrinology; 2005 Dec 15; 146(12):5350-7. PubMed ID: 16150916
    [Abstract] [Full Text] [Related]

  • 24. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.
    Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546
    [Abstract] [Full Text] [Related]

  • 25. Novel activities of pro-IGF-I E peptides: regulation of morphological differentiation and anchorage-independent growth in human neuroblastoma cells.
    Kuo YH, Chen TT.
    Exp Cell Res; 2002 Oct 15; 280(1):75-89. PubMed ID: 12372341
    [Abstract] [Full Text] [Related]

  • 26. Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation.
    Sarbassov DD, Peterson CA.
    Mol Endocrinol; 1998 Dec 15; 12(12):1870-8. PubMed ID: 9849961
    [Abstract] [Full Text] [Related]

  • 27. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes.
    Boney CM, Gruppuso PA, Faris RA, Frackelton AR.
    Mol Endocrinol; 2000 Jun 15; 14(6):805-13. PubMed ID: 10847583
    [Abstract] [Full Text] [Related]

  • 28. Acidic substitution of the activation loop tyrosines in TrkA supports nerve growth factor-dependent, but not nerve growth factor-independent, differentiation and cell cycle arrest in the human neuroblastoma cell line, SY5Y.
    Gryz EA, Meakin SO.
    Oncogene; 2003 Nov 27; 22(54):8774-85. PubMed ID: 14647472
    [Abstract] [Full Text] [Related]

  • 29. IGF-I increases IGFBP-5 and collagen alpha1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells.
    Xin X, Hou YT, Li L, Schmiedlin-Ren P, Christman GM, Cheng HL, Bitar KN, Zimmermann EM.
    Am J Physiol Gastrointest Liver Physiol; 2004 May 27; 286(5):G777-83. PubMed ID: 15068962
    [Abstract] [Full Text] [Related]

  • 30. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
    Thimmaiah KN, Easton J, Huang S, Veverka KA, Germain GS, Harwood FC, Houghton PJ.
    Cancer Res; 2003 Jan 15; 63(2):364-74. PubMed ID: 12543789
    [Abstract] [Full Text] [Related]

  • 31. Anchorage-independent activation of mitogen-activated protein kinase through phosphatidylinositol-3 kinase by insulin-like growth factor I.
    Suzuki K, Takahashi K.
    Biochem Biophys Res Commun; 2000 May 27; 272(1):111-5. PubMed ID: 10872812
    [Abstract] [Full Text] [Related]

  • 32. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
    Besset V, Scott RP, Ibáñez CF.
    J Biol Chem; 2000 Dec 15; 275(50):39159-66. PubMed ID: 10995764
    [Abstract] [Full Text] [Related]

  • 33. ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth.
    Motegi A, Fujimoto J, Kotani M, Sakuraba H, Yamamoto T.
    J Cell Sci; 2004 Jul 01; 117(Pt 15):3319-29. PubMed ID: 15226403
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
    Zapf-Colby A, Eichhorn J, Webster NJ, Olefsky JM.
    Oncogene; 1999 Sep 02; 18(35):4908-19. PubMed ID: 10490825
    [Abstract] [Full Text] [Related]

  • 35. Limited redundancy of survival signals from the type 1 insulin-like growth factor receptor.
    Navarro M, Baserga R.
    Endocrinology; 2001 Mar 02; 142(3):1073-81. PubMed ID: 11181521
    [Abstract] [Full Text] [Related]

  • 36. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor.
    Hayashi H, Ichihara M, Iwashita T, Murakami H, Shimono Y, Kawai K, Kurokawa K, Murakumo Y, Imai T, Funahashi H, Nakao A, Takahashi M.
    Oncogene; 2000 Sep 14; 19(39):4469-75. PubMed ID: 11002419
    [Abstract] [Full Text] [Related]

  • 37. Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression.
    Soon L, Flechner L, Gutkind JS, Wang LH, Baserga R, Pierce JH, Li W.
    Mol Cell Biol; 1999 May 14; 19(5):3816-28. PubMed ID: 10207105
    [Abstract] [Full Text] [Related]

  • 38. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
    Uddin S, Majchrzak B, Wang PC, Modi S, Khan MK, Fish EN, Platanias LC.
    Biochem Biophys Res Commun; 2000 Apr 02; 270(1):158-62. PubMed ID: 10733921
    [Abstract] [Full Text] [Related]

  • 39. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation.
    Lingohr MK, Dickson LM, McCuaig JF, Hugl SR, Twardzik DR, Rhodes CJ.
    Diabetes; 2002 Apr 02; 51(4):966-76. PubMed ID: 11916914
    [Abstract] [Full Text] [Related]

  • 40. Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells.
    Lu Y, Zi X, Zhao Y, Pollak M.
    Biochem Biophys Res Commun; 2004 Jan 16; 313(3):709-15. PubMed ID: 14697248
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.